Medical News

RSS

Scientists track public health trends through Twitter

Twitter allows millions of social media fans to comment in 140 characters or less on just about anything: an actor's outlandish behavior, an earthquake's tragic toll or the great taste of a grilled cheese sandwich.

8 Jul 2011

Primary function of sex is not to promote diversity, but to maintain a species' identity

Biology textbooks maintain that the main function of sex is to promote genetic diversity. But Henry Heng, Ph.D., associate professor in WSU's Center for Molecular Medicine and Genetics, says that's not the case.

8 Jul 2011

Next phase of HIV programming must focus on sustainable health systems response

"Now, we are in the Third-Generation of AIDS programming, in which the focus must be on a sustainable, health systems response, especially in the countries most affected by HIV & AIDS," Jonathan Quick, president and CEO of Management Sciences for Health, writes on the organization's "Global Health Impact" blog.

8 Jul 2011

Shire files lawsuit against Watson over generic Vyvanse

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.

8 Jul 2011

First dog enters ADXS-HER2 dose-ranging study in canine osteosarcoma

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announces that the first dog has entered a dose-ranging in canine osteosarcoma at the University of Pennsylvania School of Veterinary Medicine.

8 Jul 2011

Obama defends U.S. foreign aid spending during Twitter Town Hall meeting

"President Barack Obama on Wednesday held his first-ever 'Town Hall' meeting using the social media network Twitter, focusing on the U.S. economy and jobs," VOA News reports (Robinson, 6/7).

8 Jul 2011

Merck decides not to advance IMO-2055 development for squamous cell carcinoma of the head and neck

Idera Pharmaceuticals today provides an update on the clinical development of IMO-2055 (EMD 1201081), a TLR9 agonist for cancer treatment being developed by Merck KGaA, Darmstadt, Germany, under its collaboration with Idera.

8 Jul 2011

Extensive genomic, transcriptional diversity identified through massively parallel DNA and RNA sequencing

In a paper published in the online edition of Nature Genetics on July 3, 2011, sequencing specialists at Axeq Technologies, and scientists from Macrogen Inc., Genomic Medicine Institute at Seoul National University, Psoma Therapeutics Inc., Brigham and Women's Hospital and Harvard Medical School reported the discovery of a wide range of novel genetic variants based on the deep sequencing of 18 genomes and 17 transcriptomes of unrelated Korean individuals.

8 Jul 2011

Infectious adenoviruses and noroviruses in bathing water could pose a risk to health

European researchers have found viruses in nearly 40% of more than 1,400 bathing water samples gathered from coastal and inland areas in nine countries, including Spain. The concentrations found are low, but the scientists are calling for these microorganisms to be monitored in recreational waters, above all at times when their populations skyrocket, as is the case after heavy rains.

8 Jul 2011

Emergency aid will ease East African hunger, but it's not the solution

In a Guardian opinion piece, Nicholas Young, chief executive of the British Red Cross, writes about ongoing hunger in East Africa and how it ideally should be addressed. "Today's situation is so dire that in many cases emergency food aid is the only realistic option.

8 Jul 2011

Study finds higher rate of switching from Byetta to Victoza in treatment of type 2 diabetes

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that although Amylin/Eli Lilly's Byetta currently commands a higher patient share than Novo Nordisk's Victoza, more patients were switched from Byetta to Victoza than vice versa (25.2 percent versus 2.8 percent) in the last quarter of 2010 among recently treated type 2 diabetes patients.

8 Jul 2011

New human syndrome features craniosynostosis, maxillary hyperplasia, delayed tooth eruption, extra teeth

Researchers at the University of Helsinki, Finland, have described a new, recessively inherited human syndrome featuring craniosynostosis, maxillary hyperplasia, delayed tooth eruption and extra teeth. The researchers also identified causative mutations in a gene IL11RA.

8 Jul 2011

Cash incentives for vaccination are ethical and economical

Orin Levine, executive director of the International Vaccine Access Center, and Amanda Glassman, director of global health policy and a research fellow at the Center for Global Development, in this CGD "Global Health Policy" blog post present their reasons as to why cash transfers for vaccinations are economically and ethically sound.

8 Jul 2011

German Court announces negative decision regarding validity of Aerocrine patent

Aerocrine AB today announced a negative decision by the Munich Court regarding the validity of one German Aerocrine patent. This decision does not influence Medisoft's obligation to respect the existing three courts decisions in Germany.

8 Jul 2011

Portable system for highly sensitive multi-dimensional chemical analysis

By pairing an award-winning remote-detection version of NMR/MRI technology with a unique version of chromatography specifically designed for microfluidic chips, researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) have opened the door to a portable system for highly sensitive multi-dimensional chemical analysis that would be impractical if not impossible with conventional technologies.

8 Jul 2011

California lawmakers advance effort to review premium increases

A bill that would allow California officials to review health insurance premium increases advances as consumer groups and doctors in Connecticut lament the governor's veto of a rate review bill. Politico also reports that the federal government is preparing to step in for rate reviews in 10 states.

8 Jul 2011

Corporates profit from pinkwashing

Companies that try to increase sales of their products by adopting the color pink and pink ribbons to imply that they support breast cancer research-a practice called pinkwashing-but at the same time permit the use of chemicals shown to cause cancer are committing a form of social injustice against women, according to a thought-provoking article in Environmental Justice.

8 Jul 2011

XLR paediatric-optimized MRI workflow to address unmet need in imaging

HTX announced today it provided $475,385 in financing to XLR lmaging Inc. through their Technology Acceleration Program. The company is developing a complete paediatric-optimized MRI workflow solution designed to directly address the unique challenges in paediatric imaging while developing high resolution images and reducing scan times.

8 Jul 2011

Budget talks show movement; Changes to Medicare, Medicaid on the table

Touching these safety net programs would raise the ire of some Democrats, but the concept is being advanced by President Barack Obama as a trade-off for new tax revenues.

8 Jul 2011

Pediatricians debunk pearls of medical wisdom

Don't Cross Your Eyes-They'll Get Stuck that Way!, a new book by myth-fighting Indiana University School of Medicine pediatricians Aaron Carroll, M.D., M.S., and Rachel Vreeman, M.D., M.S., debunks the pearls of medical wisdom that many people and even their physicians believe are true. Be prepared to revise your thinking; no, an apple a day won't keep the doctor away and no, warm milk won't help you sleep.

8 Jul 2011